228 related articles for article (PubMed ID: 29860836)
21. A Multifunctional Nanotherapy for Targeted Treatment of Colon Cancer by Simultaneously Regulating Tumor Microenvironment.
Zhang Q; Zhang F; Li S; Liu R; Jin T; Dou Y; Zhou Z; Zhang J
Theranostics; 2019; 9(13):3732-3753. PubMed ID: 31281510
[TBL] [Abstract][Full Text] [Related]
22. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D
Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, characterization, and cytotoxicity assessment of N-acetyl-l-cysteine capped ZnO nanoparticles as camptothecin delivery system.
Li C; Zhang H; Gong X; Li Q; Zhao X
Colloids Surf B Biointerfaces; 2019 Feb; 174():476-482. PubMed ID: 30497009
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of MDR1 gene expression and enhancing cellular uptake for effective colon cancer treatment using dual-surface-functionalized nanoparticles.
Xiao B; Zhang M; Viennois E; Zhang Y; Wei N; Baker MT; Jung Y; Merlin D
Biomaterials; 2015 Apr; 48():147-60. PubMed ID: 25701040
[TBL] [Abstract][Full Text] [Related]
25. The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018).
Lam W; Jiang Z; Guan F; Hu R; Liu SH; Chu E; Cheng YC
BMC Complement Altern Med; 2014 Dec; 14():490. PubMed ID: 25510341
[TBL] [Abstract][Full Text] [Related]
26. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
[TBL] [Abstract][Full Text] [Related]
27. Rational Design of a New Self-Codelivery System from Redox-Sensitive Camptothecin-Cytarabine Conjugate Assembly for Effectively Synergistic Anticancer Therapy.
He W; Hu X; Jiang W; Liu R; Zhang D; Zhang J; Li Z; Luan Y
Adv Healthc Mater; 2017 Dec; 6(24):. PubMed ID: 29076266
[TBL] [Abstract][Full Text] [Related]
28. The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: Evaluation of their potential for colon-specific delivery.
Ma Y; Fuchs AV; Boase NR; Rolfe BE; Coombes AG; Thurecht KJ
Eur J Pharm Biopharm; 2015 Aug; 94():393-403. PubMed ID: 26117186
[TBL] [Abstract][Full Text] [Related]
29. CD147 Monoclonal Antibody Targeted Reduction-Responsive Camptothecin Polyphosphoester Nanomedicine for Drug Delivery in Hepatocellular Carcinoma Cells.
Tian H; Huang Y; He J; Zhang M; Ni P
ACS Appl Bio Mater; 2021 May; 4(5):4422-4431. PubMed ID: 35006854
[TBL] [Abstract][Full Text] [Related]
30. Hyaluronic acid-tagged silica nanoparticles in colon cancer therapy: therapeutic efficacy evaluation.
Liu K; Wang ZQ; Wang SJ; Liu P; Qin YH; Ma Y; Li XC; Huo ZJ
Int J Nanomedicine; 2015; 10():6445-54. PubMed ID: 26491300
[TBL] [Abstract][Full Text] [Related]
31. TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis.
Xiao B; Chen Q; Zhang Z; Wang L; Kang Y; Denning T; Merlin D
J Control Release; 2018 Oct; 287():235-246. PubMed ID: 30107214
[TBL] [Abstract][Full Text] [Related]
32. Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice.
Bissery MC; Vrignaud P; Lavelle F; Chabot GG
Anticancer Drugs; 1996 Jun; 7(4):437-60. PubMed ID: 8826613
[TBL] [Abstract][Full Text] [Related]
33. Effective intracellular delivery of bevacizumab via PEGylated polymeric nanoparticles targeting the CD44v6 receptor in colon cancer cells.
Baião A; Sousa F; Oliveira AV; Oliveira C; Sarmento B
Biomater Sci; 2020 Jul; 8(13):3720-3729. PubMed ID: 32500879
[TBL] [Abstract][Full Text] [Related]
34. Anticancer activity of polymeric nanoparticles containing linoleic acid-SN38 (LA-SN38) conjugate in a murine model of colorectal cancer.
Cheng G; Zhang X; Chen Y; Lee RJ; Wang J; Yao J; Zhang Y; Zhang C; Wang K; Yu B
Colloids Surf B Biointerfaces; 2019 Sep; 181():822-829. PubMed ID: 31247407
[TBL] [Abstract][Full Text] [Related]
35. Multifunctional nanoparticles co-delivering EZH2 siRNA and etoposide for synergistic therapy of orthotopic non-small-cell lung tumor.
Yuan ZQ; Chen WL; You BG; Liu Y; Yang SD; Li JZ; Zhu WJ; Zhou XF; Liu C; Zhang XN
J Control Release; 2017 Dec; 268():198-211. PubMed ID: 29061511
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
[TBL] [Abstract][Full Text] [Related]
37. The camptothecin derivative CPT-11 inhibits angiogenesis in a dual-color imageable orthotopic metastatic nude mouse model of human colon cancer.
Ji Y; Hayashi K; Amoh Y; Tsuji K; Yamauchi K; Yamamoto N; Tsuchiya H; Tomita K; Bouvet M; Hoffman RM
Anticancer Res; 2007; 27(2):713-8. PubMed ID: 17465193
[TBL] [Abstract][Full Text] [Related]
38. Sequential targeted delivery of paclitaxel and camptothecin using a cross-linked "nanosponge" network for lung cancer chemotherapy.
Hariri G; Edwards AD; Merrill TB; Greenbaum JM; van der Ende AE; Harth E
Mol Pharm; 2014 Jan; 11(1):265-75. PubMed ID: 24215299
[TBL] [Abstract][Full Text] [Related]
39. Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma.
Householder KT; DiPerna DM; Chung EP; Wohlleb GM; Dhruv HD; Berens ME; Sirianni RW
Int J Pharm; 2015 Feb; 479(2):374-80. PubMed ID: 25562639
[TBL] [Abstract][Full Text] [Related]
40. Development of pH-Sensitive Cationic PEGylated Solid Lipid Nanoparticles for Selective Cancer-Targeted Therapy.
Chuang CH; Wu PC; Tsai TH; Fang YP; Tsai YH; Cheng TC; Huang CC; Huang MY; Chen FM; Hsieh YC; Lin WW; Tsai MJ; Cheng TL
J Biomed Nanotechnol; 2017 Feb; 13(2):192-03. PubMed ID: 29377649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]